Experiment 383352
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | VARTERASIAN,ML: MOHAMMAD,RM: EILENDR,DS: HULBURD,K: RODRIGUEZ,DH: PEMBERTON,PA: PLUDA,JM: DAN,MD: PETTIT,GR: CHEN,BDM: AL-KATIB,AM:. (1998). PHASE I STUDY OF BRYOSTATIN 1 IN PATIENTS WITH RELAPSED NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA.. 16(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | COMPOUND WAS ADMINISTERED TO PATIENTS WITH RELAPSED NON-HODGKIN'S LYMPHOMA CHRONIC LYMPHOCYTIC LEUKEMIA IN A CONTINUOUS DIFFUSION OVER 72 HR EVERY 2 WK IN THIS PHASE I TRIAL. |
| Dose amount | 120.0 MCG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | MAXIMUM TOLERATED DOSE |